Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting

21 Feb 2023

Abstract excerpt

According to the current guidelines, watchful waiting (WW) is a feasible option for patients with good or intermediate prognosis renal-cell carcinoma (RCC). However, some patients rapidly progress during WW, requiring the initiation of treatment. Here, we explore whether we can identify those patients using circulating cell-free DNA (cfDNA) methylation. We first defined a panel of RCC-specific circulating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36900167
DOI: 10.3390/cancers15051374

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful WaitingPMID 36900167Read ↗

High-throughput methylation sequencing reveals novel biomarkers for the early detection of renal cell carcinomaSemantic proximity Read ↗

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinomaSemantic proximity Read ↗

DNA methylation is a key determinant of response to targeted and immune checkpoint therapies in metastatic renal cell carcinomaSemantic proximity Read ↗

Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaSemantic proximity Read ↗

Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinomaSemantic proximity Read ↗

Plasma cell-free DNA methylomes for hepatocellular carcinoma detection and monitoring after liver resection or transplantationSemantic proximity Read ↗

Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinomaSemantic proximity Read ↗

High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragmentsSemantic proximity Read ↗

Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy TestsSemantic proximity Read ↗

Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaSemantic proximity Read ↗

Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosisSemantic proximity Read ↗

Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNASemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.